Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India Urges Public-Private Partnerships For State-Owned Pharma Units

This article was originally published in PharmAsia News

Executive Summary

FRANKFURT, Germany - Indian Drugs and Pharmaceuticals Ltd., one of India's oldest government-owned units, is shedding its staid image and extending expertise and facilities to other drug companies through potential collaborations or joint ventures. Established in 1961, IDPL was formed with a socialistic outlook of fulfilling medical needs for the poor population in India

You may also be interested in...



India Seeks Partners With Pharmas, Hospitals To Make HIV Drugs

Indian health authorities are requesting public-sector drug makers to manufacture low-cost drugs against HIV. The government has plans to join with major pharmaceutical companies and hospitals to develop other vital drugs at affordable prices. Indian drug makers already have offered to cooperate with the government, but have expressed a desire for a public-private partnership to develop the drugs. The proposed link with the private sector and hospitals would expand the HIV effort to include anti-cancer and other drugs for life-threatening diseases, but which are considered too expensive since they are to be taken over a long term. (Click here for more

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067055

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel